Severity: Warning
Message: filesize(): stat failed for /var/cpanel/php/sessions/ea-php56/ci_sessionsa9h1r5s4l8vc7fjohid3l0tdmj854dn
Filename: drivers/Session_files_driver.php
Line Number: 212
Backtrace:
File: /home/hhcl/public_html/application/controllers/Home.php
Line: 5
Function: __construct
File: /home/hhcl/public_html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Cannot send session cache limiter - headers already sent (output started at /home/hhcl/public_html/system/core/Exceptions.php:271)
Filename: Session/Session.php
Line Number: 143
Backtrace:
File: /home/hhcl/public_html/application/controllers/Home.php
Line: 5
Function: __construct
File: /home/hhcl/public_html/index.php
Line: 316
Function: require_once
Result:
Result: Lorem ipsum simply dummy text Lorem ipsum simply dummy text Lorem ipsum
Explore diverse prescription solutions in our A-Z pharmaceutical product catalog.
View by-
The biologics vertical was conceptualized in the year 2009. With the identification of key Biosimilars and helmed by a multi-disciplinary team of over 200 specialists, R&D commenced soon at the Hetero Research Foundation(HRF). Hetero Biosimilars has enabled the company to join select biotech companies with the capability to develop, manufacture and commercialize complex monoclonal antibodies (mABs).Hetero has successfully launched Biosimilars of Darbepoetin alfa, Rituximab, Bevacizumab and Adalimumab and also has an ambitious pipeline of other Biosimilars.With this strength in Biosimilars "ASRA" division was carved out to serve the patients in need of Biosimilars for treating rheumatologic conditions.Over 2000 patients in India in the field of Rheumatology & Dermatolgy, are benefited by MABURA & MABAL-RA Biosimilars of Adalimumab and Rituximab and still going strong.
